Lamictal Antitrust Class Action Paused For Certification Fight
A New Jersey federal judge agreed Friday to pause a class action alleging a pay-for-delay scheme over the mood stabilizer Lamictal while GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd. fight the...To view the full article, register now.
Already a subscriber? Click here to view full article